ZPK vows to expand direct transactions with pharmacies

Published: 2007-06-20 06:59:00

Updated: 2007-06-20 06:59:00

Zuellig Pharma Korea (ZPK) has renewed its firm will to supply name-branded medicines to pharmacies, irrespective of the dispute with its associate wholesalers.

Stressing that there is no uncertainty over distribution of original medicines by 17 multinational drug manufacturers, ZPK plans to e...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK